MoonLake Immunotherapeutics (MLTX)

CIK 1821586 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for MoonLake Immunotherapeutics.

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003691
Aug 14, 2026SCHEDULE 13G0001897612-26-000611
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003483
Aug 10, 2026S-3ASR0001213900-26-087295
Aug 10, 20268-K0001213900-26-086939
Aug 10, 202610-Q0001821586-26-000010
Aug 10, 2026S-80001213900-26-087304
Jul 29, 202640001213900-26-082804
Jul 23, 202640001213900-26-080869
Jul 21, 202640001213900-26-080133
Jul 20, 202640001213900-26-079376
Jul 15, 20261440001969223-26-000787
Jul 15, 20268-K0001213900-26-078031
Jul 13, 202640001213900-26-077564
Jul 2, 202640001213900-26-074964
Jun 30, 20261440001969223-26-000744
Jun 29, 2026SCHEDULE 13D/A0000921895-26-001697
Jun 25, 20268-K0001213900-26-071721
Jun 24, 2026424B50001213900-26-071586
Jun 23, 202640001213900-26-071075
Jun 22, 202640000921895-26-001639
Jun 22, 2026424B50001213900-26-070709
Jun 22, 20268-K0001213900-26-070362
Jun 18, 202640001213900-26-070256
Jun 18, 202640001213900-26-070259